Lijie Rong

554 total citations
12 papers, 419 citations indexed

About

Lijie Rong is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Lijie Rong has authored 12 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Surgery. Recurrent topics in Lijie Rong's work include CAR-T cell therapy research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). Lijie Rong is often cited by papers focused on CAR-T cell therapy research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). Lijie Rong collaborates with scholars based in China, United States and Germany. Lijie Rong's co-authors include Jingjing Deng, Zhihai Qin, Xiaoman Liu, Hao Wu, Peihua Wu, Xueqiang Zhao, Xiao Li, Ulrike Erben, Xia Xu and Joachim Sieper and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Lijie Rong

12 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lijie Rong China	6	277	148	134	45	30	12	419
Lihi Radomir Israel	10	267 1.0×	102 0.7×	101 0.8×	26 0.6×	18 0.6×	12	386
Kristan Guenterberg United States	8	310 1.1×	261 1.8×	112 0.8×	35 0.8×	19 0.6×	9	450
Yuhua Qiu China	10	192 0.7×	134 0.9×	98 0.7×	43 1.0×	19 0.6×	27	341
Danielle A. Chisolm United States	8	238 0.9×	67 0.5×	135 1.0×	52 1.2×	21 0.7×	9	386
Erin D. Lucas Australia	8	160 0.6×	125 0.8×	163 1.2×	73 1.6×	14 0.5×	9	372
Francesca Amicarella Switzerland	8	263 0.9×	273 1.8×	86 0.6×	52 1.2×	26 0.9×	10	436
Irina Abécassis United States	6	154 0.6×	186 1.3×	147 1.1×	80 1.8×	25 0.8×	7	371
Daniela Vorholt Germany	4	226 0.8×	96 0.6×	138 1.0×	29 0.6×	9 0.3×	6	349
Anna Turletti Italy	6	148 0.5×	231 1.6×	72 0.5×	40 0.9×	36 1.2×	13	354
Kaname Oka Japan	6	324 1.2×	346 2.3×	106 0.8×	32 0.7×	14 0.5×	10	483

Countries citing papers authored by Lijie Rong

Since Specialization

Citations

This map shows the geographic impact of Lijie Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Rong more than expected).

Fields of papers citing papers by Lijie Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijie Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Rong. The network helps show where Lijie Rong may publish in the future.

Co-authorship network of co-authors of Lijie Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Lijie Rong. A scholar is included among the top collaborators of Lijie Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie Rong. Lijie Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rong, Lijie, et al.. (2025). Abstract 4799: MSLN and MUC1 dual-targeting CAR-T with conditional activation and tumor specificity to improve clinical safety and efficacy. Cancer Research. 85(8_Supplement_1). 4799–4799. 1 indexed citations

Sun, Yan, Lijie Rong, Dan Sun, et al.. (2025). Safety and efficacy of non-viral aPD1-MSLN JL-lightning–CAR-T in advanced malignant mesothelioma in a phase I trial.. Journal of Clinical Oncology. 43(16_suppl). 2534–2534. 1 indexed citations

Liu, Xiangzhen, Tao Liu, Haixia Gao, et al.. (2022). Evaluation of Nonviral piggyBac and lentiviral Vector in Functions of CD19chimeric Antigen Receptor T Cells and Their Antitumor Activity for CD19+ Tumor Cells. Frontiers in Immunology. 12. 802705–802705. 9 indexed citations

Rong, Lijie, Tomasz B. Owczarek, Rivka L. Shoulson, et al.. (2021). Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression. Cancer Research. 81(20). 5161–5175. 16 indexed citations

Zhao, Bo, Jianhuang Lin, Lijie Rong, et al.. (2019). ARID1A promotes genomic stability through protecting telomere cohesion. Nature Communications. 10(1). 4067–4067. 40 indexed citations

Owczarek, Tomasz B., Takashi Kobayashi, Ricardo J. Ramirez, et al.. (2017). ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer. Cancer Research. 77(4). 1035–1046. 12 indexed citations

Rong, Lijie, Yangyang Bian, Shubai Liu, et al.. (2017). Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis. Oncotarget. 8(57). 97231–97245. 5 indexed citations

Barlow, LaMont, Rebecca Meyer, David Golombos, et al.. (2017). MP48-09 INTEGRIN SIGNALING MODULATION DEMONSTRATES POTENTIAL THERAPEUTIC STRATEGY IN BLADDER CANCER USING THREE-DIMENSIONAL ORGANOID CULTURE. The Journal of Urology. 197(4S). 1 indexed citations

Deng, Jingjing, Xiaoman Liu, Lijie Rong, et al.. (2014). IFNγ‐responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down‐regulation of Dll4. The Journal of Pathology. 233(2). 170–182. 30 indexed citations

10.

Deng, Jingjing, et al.. (2013). TNFR-1 on tumor cells contributes to the sensitivity of fibrosarcoma to chemotherapy. Protein & Cell. 4(5). 393–401. 3 indexed citations

11.

Zhao, Xueqiang, Lijie Rong, Xiao Li, et al.. (2012). TNF signaling drives myeloid-derived suppressor cell accumulation. Journal of Clinical Investigation. 122(11). 4094–4104. 296 indexed citations

12.

Liu, Shubai, Lijie Rong, Jingjing Deng, et al.. (2011). TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum. Cellular and Molecular Immunology. 8(2). 164–171. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact